NCT06852417

Brief Summary

The goal of this randomized controlled trial is to test whether executive attention unpacks the antidepressant effect of Baduanjin (a form of health qigong) in older adults. The main questions it aims to answer are:

  • Is Baduanjin an effective treatment to enhance executive attention in older adults with depressive symptoms?
  • Does Baduanjin work through enhanced executive attention to alleviate depressive symptoms in older adults? Researchers will compare Baduanjin with waitlist control. Participants will receive 12-week Baduanjin training (two sessions per week and 60 min per session).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
33mo left

Started Jan 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jan 2026Dec 2028

First Submitted

Initial submission to the registry

February 24, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 28, 2025

Completed
10 months until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2028

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

March 3, 2025

Status Verified

February 1, 2025

Enrollment Period

2.8 years

First QC Date

February 24, 2025

Last Update Submit

February 27, 2025

Conditions

Keywords

Health qigongBaduanjinexecutive attentiondepressive symptoms

Outcome Measures

Primary Outcomes (1)

  • Executive attention

    The Attention Network Test (ANT) will be used to assess executive attention. The ANT is a computer-based test based on a combination of Posner's cueing task and the Flanker task. Executive attention will be operationalized as the difference in reaction time (measured in ms) in congruent and incongruent trials.

    Baseline and post-intervention (12 weeks after baseline)

Secondary Outcomes (5)

  • Depressive symptoms

    Baseline and post-intervention (12 weeks after baseline)

  • Amplitude of N2 component

    Baseline and post-intervention (12 weeks after baseline)

  • Amplitude of P3 component

    Baseline and post-intervention (12 weeks after baseline)

  • Alerting

    Baseline and post-intervention (12 weeks after baseline)

  • Orienting

    Baseline and post-intervention (12 weeks after baseline)

Study Arms (2)

Baduanjin

EXPERIMENTAL

This arm is for intervention group who will receive health qigong training.

Behavioral: Health qigong training

Waitlist control

NO INTERVENTION

The arm is for control group who will not receive any training.

Interventions

Participants will receive two 60-minute Baduanjin qigong training sessions every week under the instruction and supervision of qualified qigong instructors over 12 weeks (i.e., 24 sessions in total). Baduanjin qigong consists of eight forms of gentle movements, and it takes about 10 to 15 minutes to complete a full cycle. Participants will learn to practice each form gradually over the first 12 sessions. In the remaining 12 sessions, the participants will go through all the movements 2-3 times, with guided practice on rhythmic breathing and mind regulation (attention to body and breathing) to be performed in coordination with the movements. Instructions on each movement, voice-guide audios, and demonstration videos will be provided for participants' daily self-practice. They will be advised to practice Baduanjin for at least 10 minutes every day.

Baduanjin

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have mild or severer levels of depressive symptoms, as indicated by Geriatric Depression Scale scores of 5 or above or Depression Anxiety and Stress Scale-21 depression subscale scores of 4 or above
  • self-identified as physically stable and without life-threatening diseases
  • be able to communicate in Cantonese or Mandarin.

You may not qualify if:

  • (have a history of practicing or receiving training in any form of mind-body or regular exercises (including tai chi, yoga, and qigong or regular physical activity \> 3 times/week) during the month prior to recruitment
  • have changed medications or the dose of medications prescribed for their health condition in the month prior to study enrollment
  • have a severe cognitive or language impairment, as indicated by a score of less than 21 on the Montreal Cognitive Assessment
  • receiving pharmacological treatment, electroconvulsive therapy, psychotherapy, or psychoeducation for any psychological or psychiatric condition upon the time of recruitment
  • be unable to demonstrate satisfactory standing balance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

February 24, 2025

First Posted

February 28, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

October 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

March 3, 2025

Record last verified: 2025-02